Cooperative activation of human TLR9 and consequences for the clinical development of antisense and CpG oligodeoxynucleotides

被引：1
|
作者：
Hartmann, Gunther [1 ]
机构：
[1] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Campus Venusberg, Bonn, Germany
来源：
MOLECULAR THERAPY NUCLEIC ACIDS | 2023年 / 34卷
关键词：
B-CELL ACTIVATION;
D O I：
10.1016/j.omtn.2023.102078
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] TLR9介导CpG激活免疫细胞
    徐薇
    熊思东
    生命的化学, 2001, (03) : 198 - 200
  • [42] Targeted delivery of antigens and CpG oligonucleotides to intracellular TLR9 receptors
    Salem, Aliasger K.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [43] Reply to: "Bepirovirsen/GSK3389404: Antisense or TLR9 agonists?"
    You, Shihyun
    Elston, Robert
    Yuen, Man-Fung
    JOURNAL OF HEPATOLOGY, 2023, 78 (03) : E108 - E110
  • [44] Activation of CpG-ODN-Induced TLR9 Signaling Inhibited by Interleukin-37 in U937 Human Macrophages
    Kim, Seong-Kyu
    Choe, Jung-Yoon
    Park, Ki-Yeun
    YONSEI MEDICAL JOURNAL, 2021, 62 (11) : 1023 - 1031
  • [45] Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling
    Xie, Liang
    He, Songqing
    Kong, Na
    Zhu, Ying
    Tang, Yi
    Li, Jianhua
    Liu, Zhengbing
    Liu, Jing
    Gong, Jianbin
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (04) : 1389 - 1398
  • [46] Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9
    Yuyi Zhang
    Ang Lin
    Cai Zhang
    Zhigang Tian
    Jian Zhang
    Cancer Immunology, Immunotherapy, 2014, 63 : 357 - 367
  • [47] Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9
    Zhang, Yuyi
    Lin, Ang
    Zhang, Cai
    Tian, Zhigang
    Zhang, Jian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (04) : 357 - 367
  • [48] Lipid Nanoparticle Delivery Alters the Adjuvanticity of the TLR9 Agonist CpG by Innate Immune Activation in Lymphoid Tissue
    Zhong, Zifu
    Chen, Yong
    Deswarte, Kim
    Lauwers, Heleen
    De Lombaerde, Emily
    Cui, Xiaole
    Van Herck, Simon
    Ye, Tingting
    Gontsarik, Mark
    Lienenklaus, Stefan
    Sanders, Niek N.
    Lambrecht, Bart N.
    De Koker, Stefaan
    De Geest, Bruno G.
    ADVANCED HEALTHCARE MATERIALS, 2023, 12 (32)
  • [49] Toll-like receptor 9 (TLR9) activation by CpG or pDNA ameliorates hepatic fibrosis associated with lymphocyte alterations
    Axelrod, Jonathan H.
    Khvalevsky, Elena
    Doron, Sarit
    Enk, Jonathan
    Melhem, Alaa
    Nechemia, Yael
    Pappo, Orit
    Haj, Madi
    Galun, Eithan
    Safadi, Rifaat
    HEPATOLOGY, 2006, 44 (04) : 575A - 575A
  • [50] Development of TLR9 agonists for cancer therapy
    Krieg, Arthur M.
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05): : 1184 - 1194
12345